ResMed Invested Capital vs Average Assets Analysis
RMD Stock | USD 184.46 0.24 0.13% |
Trend analysis of ResMed Inc balance sheet accounts such as Total Stockholder Equity of 5 B, Property Plant And Equipment Net of 804 M, Net Debt of 1.6 B or Retained Earnings of 5.1 B provides information on ResMed's total assets, liabilities, and equity, which is the actual value of ResMed Inc to its prevalent stockholders. By breaking down trends over time using ResMed balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
ResMed |
About ResMed Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of ResMed Inc at a specified time, usually calculated after every quarter, six months, or one year. ResMed Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ResMed and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ResMed currently owns. An asset can also be divided into two categories, current and non-current.
ResMed Balance Sheet Chart
ResMed Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how ResMed Inc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, ResMed's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 528.7 M, whereas Accumulated Other Comprehensive Income is projected to grow to (233 M). Add Fundamental
Total Assets
Total assets refers to the total amount of ResMed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ResMed Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on ResMed balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ResMed Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from ResMed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ResMed Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At present, ResMed's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 451 M, whereas Issuance Of Capital Stock is forecasted to decline to about 48.2 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 2.0B | 2.4B | 2.7B | 2.8B | Total Revenue | 3.6B | 4.2B | 4.9B | 5.1B |
ResMed fundamental ratios Correlations
Click cells to compare fundamentals
ResMed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ResMed fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.6B | 4.7B | 5.1B | 6.8B | 7.8B | 8.2B | |
Short Long Term Debt Total | 1.3B | 793.7M | 917.6M | 1.6B | 1.8B | 1.9B | |
Other Current Liab | 335.1M | 628.6M | 389.6M | 437.9M | 503.6M | 528.7M | |
Total Current Liabilities | 602.8M | 911.8M | 689.3M | 758.5M | 872.3M | 915.9M | |
Total Stockholder Equity | 2.5B | 2.9B | 3.4B | 4.1B | 4.7B | 5.0B | |
Property Plant And Equipment Net | 535.7M | 592.1M | 630.5M | 665.8M | 765.7M | 804.0M | |
Net Debt | 836.1M | 498.4M | 643.8M | 1.4B | 1.6B | 1.6B | |
Retained Earnings | 2.8B | 3.1B | 3.6B | 4.3B | 4.9B | 5.1B | |
Accounts Payable | 135.8M | 138.0M | 159.2M | 150.8M | 173.4M | 182.0M | |
Cash | 463.2M | 295.3M | 273.7M | 227.9M | 262.1M | 335.8M | |
Non Current Assets Total | 3.1B | 3.2B | 3.2B | 4.4B | 5.0B | 5.3B | |
Non Currrent Assets Other | 189.7M | 240.8M | 251.5M | 395.4M | 454.7M | 477.5M | |
Cash And Short Term Investments | 463.2M | 295.3M | 273.7M | 227.9M | 262.1M | 340.4M | |
Net Receivables | 474.6M | 614.3M | 576.0M | 704.9M | 810.6M | 851.2M | |
Common Stock Shares Outstanding | 145.7M | 146.5M | 147.0M | 147.5M | 169.6M | 147.3M | |
Liabilities And Stockholders Equity | 4.6B | 4.7B | 5.1B | 6.8B | 7.8B | 8.2B | |
Non Current Liabilities Total | 1.5B | 930.7M | 1.0B | 1.9B | 2.1B | 2.2B | |
Inventory | 416.9M | 457.0M | 743.9M | 998.0M | 1.1B | 1.2B | |
Other Current Assets | 168.7M | 208.2M | 337.9M | 437.0M | 502.6M | 527.7M | |
Other Stockholder Equity | (52.6M) | (1.1M) | 59.2M | 148.8M | 133.9M | 140.6M | |
Total Liab | 2.1B | 1.8B | 1.7B | 2.6B | 3.0B | 3.2B | |
Total Current Assets | 1.5B | 1.6B | 1.9B | 2.4B | 2.7B | 2.9B | |
Short Term Debt | 33.3M | 35.6M | 31.8M | 31.8M | 36.6M | 66.7M | |
Intangible Assets | 448.2M | 392.6M | 345.9M | 552.3M | 635.2M | 667.0M | |
Property Plant And Equipment Gross | 535.7M | 592.1M | 630.5M | 665.8M | 765.7M | 804.0M | |
Accumulated Other Comprehensive Income | (284.0M) | (193.5M) | (312.7M) | (272.5M) | (245.3M) | (233.0M) | |
Common Stock Total Equity | 571K | 575K | 580K | 583K | 670.5K | 417.0K | |
Common Stock | 580K | 583K | 586K | 588K | 676.2K | 435.6K | |
Other Assets | 145.6M | 240.8M | 202.3M | 261.3M | 300.5M | 315.5M | |
Good Will | 1.9B | 1.9B | 1.9B | 2.8B | 3.2B | 3.3B | |
Property Plant Equipment | 535.7M | 592.1M | 630.5M | 665.8M | 765.7M | 384.1M | |
Other Liab | 221.6M | 172.6M | 160.0M | 315.2M | 362.5M | 380.6M | |
Long Term Debt | 1.2B | 643.4M | 765.3M | 1.4B | 1.6B | 1.7B | |
Current Deferred Revenue | 98.6M | 109.6M | 108.7M | 138.1M | 158.8M | 166.7M | |
Net Tangible Assets | 158.5M | 565.2M | 1.1B | 807.3M | 726.5M | 632.7M | |
Long Term Debt Total | 1.3B | 1.2B | 643.4M | 765.3M | 880.1M | 737.7M | |
Capital Surpluse | 1.5B | 1.6B | 1.6B | 1.7B | 1.9B | 1.5B |
ResMed Investors Sentiment
The influence of ResMed's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ResMed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to ResMed's public news can be used to forecast risks associated with an investment in ResMed. The trend in average sentiment can be used to explain how an investor holding ResMed can time the market purely based on public headlines and social activities around ResMed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ResMed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ResMed's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ResMed's news discussions. The higher the estimated score, the more favorable is the investor's outlook on ResMed.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ResMed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ResMed's short interest history, or implied volatility extrapolated from ResMed options trading.
Currently Active Assets on Macroaxis
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 1.84 | Earnings Share 6.04 | Revenue Per Share 30.633 | Quarterly Revenue Growth 0.125 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.